MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) will present clinical and health economics and outcomes research (HEOR) data at the 68th American Academy of Neurology (AAN) Annual Meeting, taking place April 15-21, 2016 in Vancouver, Canada. Several presentations highlight the use of APTIOM as monotherapy and adjunctive therapy for the treatment of partial-onset seizures.
